System Transmission

Top Signal

100#1 JOB

Activity

2178Ripe

+919 today

System

Live1m

Terminal Asset View

stockNASDAQ

ENTO

$2.26+2.73%

Entero Therapeutics Inc. - Common Stock

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

24Neutral

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for ENTO

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Entero Therapeutics creates medicines for people with digestive system diseases like inflammatory bowel disease. The company runs clinical trials to test if their experimental drugs work safely. They make money from research funding, partnerships, and hope to eventually earn revenue from selling approved medications to patients and healthcare providers.

ENT

Industry Context

Entero Therapeutics operates in the biotech sector, which focuses on developing new medical treatments. This industry is known for high volatility because companies spend years in research and clinical trials before potentially earning revenue from approved drugs. Investors watch for news about trial results, regulatory approvals, and partnerships that can significantly impact stock prices.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

21Matrix

Market Momentum

47.7— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

1.5x— Normal Volume

Today's Change

2.73%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ENTO across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:50 PM UTC

As-of 03-15-2026 16:35 UTC

Develops drugs that treat gut diseases and makes money by selling these medicines to hospitals and pharmacies.

Price below key moving averages, suggesting a downtrend as sellers have dominated recent trading showing consolidation pattern.

Biotech sector volatility remains high, watch for industry-wide sentiment shifts affecting clinical-stage companies, suggesting clinical-stage.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...